115 related articles for article (PubMed ID: 36060024)
1. Variants in
Kurihara S; Matsui H; Ohtake N; Aoki M; Sekine Y; Arai S; Koike H; Suzuki K; Miyazawa Y
Cancer Diagn Progn; 2022; 2(5):542-548. PubMed ID: 36060024
[TBL] [Abstract][Full Text] [Related]
2. Germline Variants of Prostate Cancer in Japanese Families.
Hayano T; Matsui H; Nakaoka H; Ohtake N; Hosomichi K; Suzuki K; Inoue I
PLoS One; 2016; 11(10):e0164233. PubMed ID: 27701467
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
Heise M; Jarzemski P; Nowak D; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Borysiak M; Pilarska B; Haus O
Cancer Control; 2022; 29():10732748211062342. PubMed ID: 35638715
[No Abstract] [Full Text] [Related]
4. HOXB13 mutations in a population-based, case-control study of prostate cancer.
Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
[TBL] [Abstract][Full Text] [Related]
5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.
Decker B; Ostrander EA
Pharmgenomics Pers Med; 2014; 7():193-201. PubMed ID: 25206306
[TBL] [Abstract][Full Text] [Related]
7. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
[TBL] [Abstract][Full Text] [Related]
8. Association of homeobox B13 (HOXB13) gene variants with prostate cancer risk in an Iranian population.
Roudi R; Nemati H; Rastegar Moghadam M; Sotoudeh M; Narouie B; Shojaei A
Med J Islam Repub Iran; 2018; 32():97. PubMed ID: 31024864
[No Abstract] [Full Text] [Related]
9. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
[TBL] [Abstract][Full Text] [Related]
11. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer.
Kanayama M; Chen Y; Rabizadeh D; Vera L; Lu C; Nielsen SM; Russell EM; Esplin ED; Wang H; Isaacs WB; Antonarakis ES; Luo J
Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37806842
[TBL] [Abstract][Full Text] [Related]
13. The HOXB13 p.Gly84Glu variant observed in an extended five generation high-risk prostate cancer pedigree supports risk association for multiple cancer sites.
Cannon-Albright LA; Stevens J; Teerlink CC; Agarwal N
Cancer Epidemiol; 2020 Dec; 69():101834. PubMed ID: 33099213
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic mechanisms of
Cardoso M; Maia S; Paulo P; Teixeira MR
Oncoscience; 2016; 3(9-10):288-296. PubMed ID: 28050579
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Germline DNA Repair Gene and
Boyle JL; Hahn AW; Kapron AL; Kohlmann W; Greenberg SE; Parnell TJ; Teerlink CC; Maughan BL; Feng BJ; Cannon-Albright L; Agarwal N; Cooney KA
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923906
[TBL] [Abstract][Full Text] [Related]
16. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
17. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
20. Familial prostate cancer.
Giri VN; Beebe-Dimmer JL
Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]